-
New data show that FIRMAGON® (degarelix) is non-inferior to the combination of goserelin plus bicalutamide at reducing prostate volume in patients with advanced hormone-dependent prostate cancer while offering better relief from lower urinary tract symptoms
-Two new studies presented at the 27th Annual European Association of Urology (EAU) Congress reported that…
0 -
Ferring announces new million euro educational initiative with International Federation of Fertility Societies (IFFS) and Elsevier
-World leader in fertility treatments, Ferring Pharmaceuticals, announced today at the 2012 Updates in Infertility Treatment (UIT) meeting that…
Archive for February, 2012
2012 > February